PRKG1 and neurodegenerative disease: Through its interaction with cGMP, the binding domain of PKG binds to cGMP, activates the catalytic domain of PKG, and affects the phosphorylation state of various effector molecules, thereby playing a crucial role in neurodegenerative diseases (NDDs) (VerPlank et al, 2020).